Associated Papers
Disease-associated mutations in the STAT5B SH2 domain reprogram hepatic cholesterol and lipid metabolism.
Lee HK et al.
Biorxiv : the Preprint Server for Biology, 2025
STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs.
Lee HK et al.
Life Science Alliance, 2025
Disease-Associated Mutations of the STAT5B SH2 Domain Regulate Cytokine-Driven Enhancer Function and Mammary Development.
Lee HK et al.
Journal of Mammary Gland Biology and Neoplasia, 2025
STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programs.
Lee HK et al.
Biorxiv : the Preprint Server for Biology, 2024
STAT5B SH2 variants disrupt mammary enhancers and the stability of genetic programs during pregnancy.
Lee HK et al.
Biorxiv : the Preprint Server for Biology, 2024
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL.
Wahnschaffe L et al.
Cancers, 2019
31766351 (PubMed )
Supplement: cancers-11-01833-s001.zip › Supplementary_Table_3.xlsx › Tabelle1
Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED et al.
Cancers, 2019
STAT5BN642H is a driver mutation for T cell neoplasia.
Pham HTT et al.
The Journal of Clinical Investigation, 2018
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
Kiel MJ et al.
Blood, 2014
Select a paper to view details